ACRIA NewsWinter 2004/2005
ACRIA Study of SAM-e PublishedOn November 11, 2004, the peer-review journal, BMC Psychiatry (www.biomedcentral.com/bmcpsychiatry), published results from ACRIA's independent pilot study of SAM-e (S-Adenosylmethionine) used to treat depression in HIV patients. ACRIA decided to study SAM-e because there are repeated reports of high levels of untreated depression in the HIV population. Many people are reluctant to add yet another drug with potential side effects to their already onerous anti-HIV drug regimens. Fortunately, our study showed promise with the use of this natural alternative (SAM-e). Publication in a peer-reviewed journal is a demanding process. Yet this process is essential; otherwise the results would not be known or trusted. Since the study results were promising, ACRIA is now planning to conduct a larger clinical study of SAM-e, possibly in older adults with HIV who have been diagnosed with clinical depression. There is still too little clinical data on the efficacy of this agent. Hopefully, our further examination of SAM-e will serve to confirm its potential benefits for people living with HIV.
ACRIA Presents at Gerontological Society Scientific MeetingACRIA's research staff was invited to present our seminal data on an over 50 HIV population at the 2004 Annual Scientific Meeting of the Gerontological Society of America November 19-23, 2004. This meeting represented the first time in the society's history to offer a symposium specifically on the aging HIV population. ACRIA was naturally very pleased to have played a central role in discussing this emerging topic of interest to gerontology researchers and care providers of older populations across the United States. ACRIA's presentations were:
Anyone interested in reading the abstracts and viewing the PowerPoint slides used for these presentations can visit the Research section of www.acria.org.
This article was provided by AIDS Community Research Initiative of America. It is a part of the publication ACRIA Update. |